La Jolla Pharmaceutical Company (NASDAQ:LJPC) Director, Kevin Tang, Acquires 169,555 Shares

Boston, MA 09/29/2014 (wallstreetpr) – One of the major shareholder and Director of La Jolla Pharmaceutical Company (NASDAQ:LJPC), Kevin Tang, has resorted to accumulating shares of the company in the last three trading sessions of the last week. This is the second transaction of insider trading activities during the current month of September. Buys Shares La […]

Wall Street Briefing: La Jolla Pharmaceutical Company (NASDAQ:LJPC), WELL POWER INC (OTCBB:WPWR), Tiger Oil And Energy Inc (OTCMKTS:TGRO)

Boston, MA 03/13/2014 (wallstreetpr) – La Jolla Pharmaceutical Company (NASDAQ:LJPC) had its shares changing hands last at $15.82 after falling $11.92 percent Wednesday. Earlier in the day the shares soared to $17.80, marking the highest intraday price level. The Wednesday trading was characterized with larger volume of shares changing hands than in a normal session. […]

La Jolla Pharmaceutical Company (NASDAQ:LJPC) Lead Product Candidate Covered By New Patent Allowed

Boston, MA 02/27/2014 (wallstreetpr) – La Jolla Pharmaceutical Company (NASDAQ:LJPC) which is a $35.15 million market capped biopharma company recently announced allowed patent notice. It is now emerging that the allowed patent covers the company’s leading product candidate. The company is concerned with the treatments aimed at inhibiting the activity of galectins so as to achieve […]